When it comes to private or employer-sponsored plans, these only provide GLP-1 weight-loss drug coverage for 13.7 million people, according to the database
Regulatory Status Disclosure: The FDA declared the semaglutide drug shortage resolved in February 2025 and the tirzepatide drug shortage resolved in October 2024
Marathe, C.S
If you are considering prescription GLP-1 treatment and want a clearer next step, find out whether a personalized GLP-1 program is a fit
It must be used as part of a comprehensive weight loss plan, which includes proper diet and exercise, with ongoing monitoring by a healthcare provider
She really listened to what I wanted, communicated actively with me, and confirmed everything carefully until I felt completely comfortable." Chicago, IL "The spa was clean, relaxing, and welcoming